Fundz

PineTree Therapeutics

Cambridge, Massachusetts, United States · Biotechnology, Health Care, Science And Engineering

Pinetree Therapeutics, based in Cambridge, MA, is a preclinical-stage biotech company developing next-generation targeted protein degraders (TPDs) to overcome drug resistance and tumor recurrence in oncology, with applications in inflammation and immunology. Its proprietary AbReptor™ platform enables selective degradation of membrane-bound and extracellular proteins, offering a differentiated mech

Key facts

Headquarters
Cambridge, Massachusetts, United States
Employees
36
Industries
Biotechnology, Health Care, Science And Engineering
Status
Private
Website
pinetreetx.com
LinkedIn
Company page

Recent activity at PineTree Therapeutics

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

PineTree Therapeutics funding history

DateRoundAmount
Oct 2025Series B$47.0M
Jun 2022Series A$23.5M

Leadership

  • Ho-Juhn Song, CEO/Founder
  • John Jia, Director
  • Seulhee Kim, Doctor
  • Donna Grant, Executive Director

Verified email and direct lines for PineTree Therapeutics’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

PineTree Therapeutics files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Companies similar to PineTree Therapeutics

About PineTree Therapeutics: questions and answers

What does PineTree Therapeutics do?

Pinetree Therapeutics, based in Cambridge, MA, is a preclinical-stage biotech company developing next-generation targeted protein degraders (TPDs) to overcome drug resistance and tumor recurrence in oncology, with applications in inflammation and immunology. Its proprietary AbReptor™ platform enables selective degradation of membrane-bound and extracellular proteins, offering a differentiated mech

Where is PineTree Therapeutics headquartered?

PineTree Therapeutics is headquartered in Cambridge, Massachusetts, United States.

How many employees does PineTree Therapeutics have?

PineTree Therapeutics has about 36 employees.

Has PineTree Therapeutics raised funding?

Yes. Fundz has recorded 2 funding events for PineTree Therapeutics. The most recent, Series B of $47.0M, was in Oct 2025.

Who leads PineTree Therapeutics?

Ho-Juhn Song is a CEO/Founder at PineTree Therapeutics.

What is the latest news on PineTree Therapeutics?

On Oct 29, 2025, Pinetree Therapeutics has raised $47 million in an oversubscribed Series B round to advance next-generation protein degraders in oncology.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches PineTree Therapeutics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.